Remarkably, a functional interaction of p53/MDM2 is dispensable for embryonic development, whereas it is essential for DDIA, thus emphasizing the potential of the p53/MDM2-interaction as a target in anti-cancer therapy (Zhao et al., 2013). This evidence concerns the gene MDM2 and cancer.